Fox Run Management, L.L.C. Veru Inc. Transaction History

Fox Run Management, L.L.C.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$4.78 - $15.01 $16,170 - $50,778	3,383 Added 23.26%	17,929 $94,000
Q3 2022 Nov 07, 2022	SELL	$10.22 - $23.7 $23,894 - $55,410	-2,338 Reduced 13.85%	14,546 $168,000
Q2 2022 Aug 12, 2022	BUY	$4.35 - $15.85 $73,445 - $267,611	16,884 New	16,884 $191,000
Q1 2022 May 10, 2022	SELL	$4.55 - $6.41 $116,439 - $164,038	-25,591 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$5.89 - $9.73 $150,730 - $249,000	25,591 New	25,591 $151,000
Q3 2021 Nov 15, 2021	SELL	$6.78 - $9.89 $70,152 - $102,331	-10,347 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$7.24 - $11.2 $2,743 - $4,244	-379 Reduced 3.53%	10,347 $84,000
Q1 2021 May 17, 2021	BUY	$8.05 - $20.78 $86,344 - $222,886	10,726 New	10,726 $116,000

122

56.8M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $46.5M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.